Growth Metrics

OptimizeRx (OPRX) Asset Writedowns and Impairment (2022 - 2025)

OptimizeRx's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $77000.0 for Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment fell 59.04% to $77000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was $77000.0, a 75.86% decrease, with the full-year FY2024 number at $208000.0, down 68.77% from a year prior.
  • Asset Writedowns and Impairment hit $77000.0 in Q4 2024 for OptimizeRx, up from -$1000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for OPRX hit a ceiling of $239000.0 in Q3 2023 and a floor of -$1000.0 in Q3 2024.
  • Historically, Asset Writedowns and Impairment has averaged $112501.1 across 3 years, with a median of $111000.0 in 2023.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 602.94% in 2023 and later plummeted 100.42% in 2024.
  • Tracing OPRX's Asset Writedowns and Impairment over 3 years: stood at $230785.0 in 2022, then dropped by 18.54% to $188000.0 in 2023, then plummeted by 59.04% to $77000.0 in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for OPRX at $77000.0 in Q4 2024, -$1000.0 in Q3 2024, and $132000.0 in Q1 2024.